Overview
Status
Active
Registry date
2024-10-29
Financials
Revenue history (in m)
Filing timeliness
Financial statements were filed on time, on average 73 days early.
- 202515/07/2026
- 202419/02/2025
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 302.74kMedianUSD 917.74kAverageUSD 25.73m
Net profit
This companyUSD -193.67kMedianUSD 14.44kAverageUSD 2.75m
Operating costs
This companyUSD 485.00kMedianUSD 860.03kAverageUSD 21.34m
Assets
This companyUSD 828.31kMedianUSD 883.09kAverageUSD 31.39m
Industry
Offer
- Medicines
- Pharmaceutical products
- Adverse reaction reporting
Website technology
- Website
- WordPress
- Analytics and marketing
- Google Tag Manager
Trademarks
Polmex Pharma Biniecki holds 2 active trademarks registered with the Polish Patent Office. The first mark was filed in 2000.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| Hemkortin-HC(word) | Z.355729 | 5 | Protected | May 12, 2029 | |
| POLMEX(word) | Z.221474 | 5, 35, 36, 42 | Protected | Jul 19, 2030 |
| Mark | Protected until | |
|---|---|---|
| Hemkortin-HC(word) | May 12, 2029 | |
| POLMEX(word) | Jul 19, 2030 |
Authorized Representatives
Alina Picazio – Attorney-in-fact (sole)
Manner of representation
Each general partner independently.
Partners
| Partners |
|---|
Krzysztof Marian Binieckiage 75 |
Alina Picazioage 56 |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1999-05-17.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Uropharmasp. z o.o. | $1,113,812.65 | uroplus.pl | ||
| Optiferricsp. z o.o. | $816,162.17 | optiferric.com | ||
| Zeptor Polskasp. z o.o. | $748,374.79 | zeptor.pl | ||
| Human BiomeS.A. | $583,508.16 | human-biome.com | ||
| Hauster sp. z o.o.sp. k. | $577,912.26 | hauster.pl | ||
| PLON Pharmsp. z o.o. | $524,792.98 | plonpharm.pl | ||
| DR Andresp. z o.o. | $453,987.42 | drandre.pl | ||
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl | ||
| Ti-Comsp. z o.o. | $157,549.77 | ticomglobal.com | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl |
FAQ
Last updated: 2026-07-15